Brief: BB Biotech 9-month Net Profit Down At CHF 26 Million
Oct 23 (Reuters) - BB Biotech AG BION.S :
* NET ASSET VALUE (NAV) DECLINED BY 10.9% IN CHF, 12.1% IN
EUR AND
8.3% IN USD IN Q3
* Q3 NET LOSS WAS CHF 395 MN, COMPARED TO A NET LOSS OF CHF
382
MILLION YEAR AGO
* 9-MONTH NET PROFIT OF CHF 26 MN COMPARES TO CHF 172 MN FOR
SAME
PERIOD IN 2019.
Source text for Eikon: ID:nEQ2jLzsqa
Further company coverage: BION.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM